Ani Pharmaceuticals (ANIP) Change in Cash (2010 - 2026)

Ani Pharmaceuticals has disclosed Change in Cash across 17 years of filings, most recently posting $25.6 million for Q1 2026.

• Change in Cash for Q1 2026 came in at $25.6 million, up 417.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $161.4 million (up 304.89% YoY), and the FY2025 annual result was $140.7 million, up 284.62% from the prior year.
• Change in Cash came in at $25.6 million for Q1 2026 at Ani Pharmaceuticals, up from $23.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $94.0 million in Q2 2023 to a low of -$95.1 million in Q3 2024.
• The 5-year median for Change in Cash is $11.5 million (2024), against an average of $12.1 million.
• Across the five-year window, Change in Cash plunged 1567.69% in 2022 and surged 18778.86% in 2025, its largest moves.
• Ani Pharmaceuticals' Change in Cash stood at -$8.0 million in 2022, then surged by 448.36% to $28.0 million in 2023, then slumped by 100.44% to -$123000.0 in 2024, then soared by 18778.86% to $23.0 million in 2025, then rose by 11.39% to $25.6 million in 2026.
• The last three Change in Cash figures came in at $25.6 million (Q1 2026), $23.0 million (Q4 2025), and $44.8 million (Q3 2025), per Business Quant data.